Adcy3−/− mice exhibit pronounced obesity, hyperphagia, and leptin resistance and lower physical activity [73], whereas the Adcy3 gain-of-function mutation results in reduced fat mass and body weights in HFD-fed mice [74]. Here, ADCY3 is linked to obesity disorder.